Canon Medical Systems announced the kickoff of new clinical research involving its photon-counting CT (PCCT) technology.
The announcement is a follow-up to an initial agreement with Hiroshima University announced in November. Led by Prof. Kazuo Awai of the Hiroshima University Department of Diagnostic Radiology, the research will explore the clinical usefulness of data captured by PCCT, evaluate and optimize various kinds of diagnostic information provided by PCCT, and determine imaging protocols in order to maximize the functionality of PCCT from a basic level to clinical applications, according to the vendor.
Canon said it will be highlighting its PCCT technology at the International Technical Exhibition of Medical Imaging 2024 (ITEM2024) to be held in Yokohama, Japan, April 12-14, and the 83rd Congress of the Japan Radiological Society and 80th Congress of the Japanese Society of Radiological Technology April 11-14.
![Axial images from unenhanced calcium score cardiac CT (left) and curved planar reformation images from CT angiography (right) show that higher long-term exposure to air pollution is associated with greater coronary artery calcium and more obstructive coronary artery disease (CAD). Top row: Images in a 68-year-old male patient with higher 10-year mean ambient air pollution exposure (7.9 μg/m3 for particulate matter measuring ≤2.5 μm in diameter [PM2.5] and 17.4 parts per billion [ppb] for NO2) with extensive CAD (coronary artery calcium score [CACS] >1,000 and obstructive CAD [≥70% diameter stenosis]). Bottom row: Images in a 57-year-old female patient with lower 10-year mean ambient air pollution exposure (6.3 μg/m3 for PM2.5 and 4.6 ppb for NO2) with no CAD (CACS = 0 and no obstructive stenosis).](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/06/hanneman.r6SMLzkezo.png?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
